BR9911079A - Acentuador de acetilcolina, composto, processo tanto para inibir a acetilcolina esterase de enzima quanto para antagonizar o receptor de serotonina 5ht3, e, composição farmacêutica. - Google Patents

Acentuador de acetilcolina, composto, processo tanto para inibir a acetilcolina esterase de enzima quanto para antagonizar o receptor de serotonina 5ht3, e, composição farmacêutica.

Info

Publication number
BR9911079A
BR9911079A BR9911079-2A BR9911079A BR9911079A BR 9911079 A BR9911079 A BR 9911079A BR 9911079 A BR9911079 A BR 9911079A BR 9911079 A BR9911079 A BR 9911079A
Authority
BR
Brazil
Prior art keywords
acetylcholine
compound
antagonize
inhibit
pharmaceutical composition
Prior art date
Application number
BR9911079-2A
Other languages
English (en)
Inventor
Derek T Chalmers
Susumu Sato
Tadayuki Koda
Original Assignee
Arena Pharm Inc
Ssp Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arena Pharm Inc, Ssp Co Ltd filed Critical Arena Pharm Inc
Publication of BR9911079A publication Critical patent/BR9911079A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

"ACENTUADOR DE ACETILCOLINA, COMPOSTO, PROCESSO TANTO PARA INIBIR A ACETILCOLINA ESTERASE DE ENZIMA QUANTO PARA ANTAGONIZAR O RECEPTOR DE SEROTONINA 5HT3, E, COMPOSIçãO FARMACêUTICA" São aqui divulgados derivados de quinolina tendo duas propriedades mecanísticas duais, referidas neste documento de patente como "acentuadores de acetilcolina ", isto é, compostos que evidenciam a atividade de inibição da acetilcolinesterase (AChE), e a atividade de antagonista do receptor 5-HT3. Um composto particularmente preferido é hemifumarato 2-[2-(1-benzilpiperizin-4-il)etil]-2,3-diidro-9-metóxi-1H-pirrolo[3,4-b]qui nolin-1-ona, aqui referido como composto A ("Cm.A").
BR9911079-2A 1998-06-10 1999-06-09 Acentuador de acetilcolina, composto, processo tanto para inibir a acetilcolina esterase de enzima quanto para antagonizar o receptor de serotonina 5ht3, e, composição farmacêutica. BR9911079A (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US8873798P 1998-06-10 1998-06-10
US9166698P 1998-07-02 1998-07-02
US10941398P 1998-11-20 1998-11-20
US11508999P 1999-01-07 1999-01-07
US13688799P 1999-06-01 1999-06-01
PCT/US1999/012886 WO1999064421A1 (en) 1998-06-10 1999-06-09 Acetylcholine enhancers
US09/328,643 US6218402B1 (en) 1998-06-10 1999-06-09 Acetylcholine enhancers

Publications (1)

Publication Number Publication Date
BR9911079A true BR9911079A (pt) 2001-02-20

Family

ID=27557353

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911079-2A BR9911079A (pt) 1998-06-10 1999-06-09 Acentuador de acetilcolina, composto, processo tanto para inibir a acetilcolina esterase de enzima quanto para antagonizar o receptor de serotonina 5ht3, e, composição farmacêutica.

Country Status (12)

Country Link
US (2) US6218402B1 (pt)
EP (1) EP1086102A1 (pt)
JP (1) JP2004508272A (pt)
KR (1) KR20010072598A (pt)
CN (1) CN1138775C (pt)
AU (1) AU751590B2 (pt)
BR (1) BR9911079A (pt)
CA (1) CA2331794A1 (pt)
IL (1) IL139254A0 (pt)
MX (1) MXPA00012248A (pt)
NO (1) NO20006249D0 (pt)
WO (1) WO1999064421A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3929250B2 (ja) * 2001-03-08 2007-06-13 株式会社ルネサステクノロジ 半導体装置
WO2004035577A2 (en) * 2002-10-16 2004-04-29 Gilead Sciences, Inc. Pre-organized tricyclic integrase inhibitor compounds
EP1677778A2 (en) * 2003-10-09 2006-07-12 Inverseon, Inc. Method of treating airway diseases with beta-adrenergic inverse agonists
US20070276024A1 (en) * 2003-10-09 2007-11-29 Inverseon , Inc. Methods for Treating Diseases and Conditions with Inverse Agonists and for Screening for Agents Acting as Inverse Agonists
JP2005154320A (ja) * 2003-11-25 2005-06-16 Ss Pharmaceut Co Ltd 眼疾患治療薬
PT1742642E (pt) * 2004-04-14 2009-01-23 Gilead Sciences Inc Análogos de fosfonato de compostos inibidores da integrase do hiv
US7528175B2 (en) * 2004-10-08 2009-05-05 Inverseon, Inc. Method of treating airway diseases with beta-adrenergic inverse agonists
CN103992312A (zh) * 2013-02-18 2014-08-20 江苏欧威医药有限公司 1,2,4-噻二唑-3,5-二酮衍生物及其药物组合物和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240934A (en) 1990-10-19 1993-08-31 Ss Pharmaceutical Co., Ltd. Quinoline derivatives
US5190951A (en) * 1990-10-19 1993-03-02 Ss Pharmaceutical Co., Ltd. Quinoline derivatives
CA2135253A1 (en) 1994-11-07 1996-05-08 Michael Dennis Compound screening based on a window of chemical-messenger-independent activity

Also Published As

Publication number Publication date
CA2331794A1 (en) 1999-12-16
MXPA00012248A (es) 2003-04-25
US6218402B1 (en) 2001-04-17
IL139254A0 (en) 2001-11-25
WO1999064421A1 (en) 1999-12-16
AU4955399A (en) 1999-12-30
NO20006249L (no) 2000-12-08
US20010039284A1 (en) 2001-11-08
KR20010072598A (ko) 2001-07-31
EP1086102A1 (en) 2001-03-28
CN1138775C (zh) 2004-02-18
AU751590B2 (en) 2002-08-22
WO1999064421B1 (en) 2000-02-24
NO20006249D0 (no) 2000-12-08
WO1999064421A8 (en) 2000-04-06
CN1304411A (zh) 2001-07-18
JP2004508272A (ja) 2004-03-18
US6586596B2 (en) 2003-07-01

Similar Documents

Publication Publication Date Title
BR9916980A (pt) Derivados bicìclicos substituìdos úteis como agentes anticancerìgenos
NO986055D0 (no) Nye heterocykliske forbindelser, deres fremstilling, farmas÷ytiske preparat
BR0010746A (pt) Derivados heterocìclicos úteis com agentes anticâncer
DE69705829D1 (de) Meta-substituierte phenylsulphonamidderivate
AU9309898A (en) Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa
BR9713552A (pt) Derivados de pirimidina bicìclicos condensados
BR9814340A (pt) Derivados de indol como inibidores de fator xa
SE9904508D0 (sv) New compounds
NO20012977L (no) N-ureidoalkylpiperidiner som modulatorer av chemokinreseptoraktivitet
BR0005633A (pt) Derivados de quinolina úteis para inibição da farnesil proteìna transferase
AU6518998A (en) Morphinane derivatives and medicinal use thereof
BR9911079A (pt) Acentuador de acetilcolina, composto, processo tanto para inibir a acetilcolina esterase de enzima quanto para antagonizar o receptor de serotonina 5ht3, e, composição farmacêutica.
BR0309748A (pt) Derivados de n-acil piperidina e composição compreendendo os mesmos
ES551522A0 (es) Procedimiento para preparar 5h, 11h-pirrolo-2,1-c-1,4 benzoxazepinas sustituidas en posicion 11
CA2378834A1 (en) Pyrazinones, compositions containing such compounds
UY26426A1 (es) Nuevos compuestos
ES2161417T3 (es) Compuestos de 2-aril-3-aminoariloxinaftilo, intermediarios, composiciones y procedimientos.
ATE253359T1 (de) Antithrombotische mittel
NO983444L (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
NO176097C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte cykloheksener
DE69828522D1 (de) Antithrombotische mittel
NO169442C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive prolinderivater og lignende forbindelser
WO2000037465A3 (en) Novel derivatives of swainsonine, processes for their preparation, and their use as therapeutic agents
DE69824410D1 (en) Antithrombosemittel
AU1434201A (en) Antithrombotic agents

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5,6,7 E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.